Suchergebnisse - (Subject:"Adalimumab")

PubPharm (2.033)

1

New-onset Blepharitis and Anti-TNF-Alpha Therapy in Patients with Crohn's Disease : A Case Series and Literature Review

enthalten in: The Israel Medical Association journal : IMAJ | 2023

von Weintraub, Y. | Lev-Tzion, R. | Ollech, J. | +6

2

Overview and therapy update Crohn's disease

enthalten in: Therapeutische Umschau. Revue therapeutique | 2023

von Frei, R. | Misselwitz, B.

3

LOSS OF EFFICACY OF ADALIMUMAB IN HIDRADENITIS SUPPURATIVA : FOCUS ON ALTERNATIVES

enthalten in: Georgian medical news | 2023

von Tchernev, G.

4

Drug Survival of Tumor Necrosis Factor-Alpha Inhibitors and Switched Subsequent Biologic Agents in Patients with Psoriasis: A Retrospective Study

enthalten in: Dermatology and therapy | 2023

von Kishimoto, M. | Komine, M. | Kamiya, K. | +4

5

Potential Predictors of Cardiovascular Risk Improvement in Patients with Hidradenitis Suppurativa Treated with Adalimumab: A Pivotal Study of Factors Associated with Carotid Intima–Media Thickness Reduction

enthalten in: Dermatology and therapy | 2023

von Sánchez-Díaz, M. | Salvador-Rodríguez, L. | Cuenca-Barrales, C. | +2

6

Adalimumab combined with erythropoietin improves recovery from spinal cord injury by suppressing microglial M1 polarization-mediated neural inflammation and apoptosis

enthalten in: Inflammopharmacology | 2023

von Liu, Y. | Zhang, F. | Sun, Q. | +1

7

Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report

enthalten in: Indian journal of otolaryngology and head & neck surgery | 2022

von Vural, S. | Kuşdoğan, M. | Kaya, H. | +2

8

A retrospective study on drug survival of biologic among patients with psoriasis seen in tertiary hospital in Johor Malaysia

enthalten in: The Medical journal of Malaysia | 2022

von Mashor, M. | Wong, K. | Tey, K. | +1

9

Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials

enthalten in: Rheumatology and therapy | 2022

von Tanaka, Y. | Atsumi, T. | Aletaha, D. | +7

10

Efficacy and Safety of Upadacitinib in Patients with Psoriatic Arthritis: 2-Year Results from the Phase 3 SELECT-PsA 1 Study

enthalten in: Rheumatology and therapy | 2022

von McInnes, I. | Kato, K. | Magrey, M. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[204]